Ablation versus medical therapy for patients with atrial fibrillation: An updated meta‐analysis
Clinical Cardiology · 2024
DOI: 10.1002/clc.24184 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Fatemeh Kheshti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke, Catheter Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To investigate the effect of ablation compared to medical therapy on clinical outcomes of patients with atrial fibrillation (AF). PubMed, Scopus, Embase, and Web of Science databases were searched using ablation, medical treatment, AF, and related words. The effect of ablation and medical therapy was sought to be gathered on stroke or transitional ischemic attack, mortality, hospitalization, recurrence of AF, progression of AF, and left ventricular ejection fraction. Analyses were performed using R software. 31 studies (the results of 27 randomized controlled trials), compromising an overall 6965 patients (Ablation, n = 3643; Medical treatment, n = 3322) were reviewed in our study, revealed that catheter ablation would result in substantial benefits for patients with AF without significant difference in serious adverse events compared to medical management (Risk Ratio: 0.92, [95% Confidence Interval (CI), 0.64−1.33]). Catheter ablation in patients with AF significantly resulted in a 29% reduction in all‐cause mortality (RR: 0.71, [95% CI, 0.57−0.88]), a 57% reduction in hospitalization (RR: 0.43, [95% CI, 0.27−0.67]), a 53% reduction in AF recurrence (RR: 0.47, [95% CI, 0.36−0.61]), and a dramatic reduction, 89%, in progression of paroxysmal to persistent AF (RR: 0.11, [95% CI, 0.02−0.65]); also associated with a remarkable improvement in their left ventricular ejection fraction (LVEF) (Mean Difference, MD: 6.84%, [95% CI, 3.27−10.42]) compared to medical therapy. Our study showed that ablation may be superior to medical therapy in patients with AF regarding AF recurrence, mortality, LVEF improvement, hospitalization, and AF progression outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Students' Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Research Center for Neuromodulation and Pain, Shiraz, Iran.
Zitieren
APA
Kheshti, F., Abdollahifard, S., Hosseinpour, A., Bazrafshan, M., & Attar, A. (2024). Ablation versus medical therapy for patients with atrial fibrillation: An updated meta‐analysis. Clinical Cardiology. https://doi.org/10.1002/clc.24184
Vancouver
Kheshti F, Abdollahifard S, Hosseinpour A, Bazrafshan M, Attar A. Ablation versus medical therapy for patients with atrial fibrillation: An updated meta‐analysis. Clinical Cardiology. 2024. doi:10.1002/clc.24184
BibTeX
@article{Kheshti2024,
author = {Kheshti, Fatemeh and Abdollahifard, Saeed and Hosseinpour, Alireza and Bazrafshan, Mehdi and Attar, Armin},
title = {Ablation versus medical therapy for patients with atrial fibrillation: An updated meta‐analysis},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.24184}
}
EUVIMED